1 / 24

The potential role of HIV self-testing within pre-exposure prophylaxis implementation

Abstract Number: TUAC0101 . The potential role of HIV self-testing within pre-exposure prophylaxis implementation . Cheryl Case Johnson World Health Organization, HIV Department Geneva, Switzerland. Pre-exposure prophylaxis ( PrEP ).

adanna
Download Presentation

The potential role of HIV self-testing within pre-exposure prophylaxis implementation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Abstract Number: TUAC0101 The potential role of HIV self-testing within pre-exposure prophylaxis implementation Cheryl Case Johnson World Health Organization, HIV Department Geneva, Switzerland

  2. Pre-exposure prophylaxis (PrEP) • Daily oral ARVs for HIV negative persons to prevent acquisition • Strong recommendation for MSM * • Conditional recommendation for other populations** • Prevention strategy for serodiscordantcouples (SDCs)** • New WHO recommendations: *WHO Consolidated KP Guidelines, 2014; **WHO Guidelines for PrEP Demonstration Projects, 2012.

  3. Pre-exposure prophylaxis (PrEP) PrEP demonstrations underway, but questions remain: • Who should take PrEP? • How should it be delivered? • How much does it cost & how can costs be reduced?

  4. Pre-exposure prophylaxis (PrEP) Cost of Re-Testing • Recommended every 3 months (CDC) for HIV negative individuals on PrEP • Can burden health workers & facilities • Can burden patients Risk of Not Re-Testing • Potential seroconversion and drug-resistant virus

  5. What is HIV self-testing (HIVST)? • Positive results need confirmation Source: WHO March 2014 supplement to ARV Guidelines

  6. Many possible HIVST models* • Potential models with varying levels of support, accessand distributionor initiation • Examined 2 facility-based models: • Supervised facility-based HIV self-testing • Unsupervised HIV self-testing alternated with facility-based testing Source: WHO March 2014 supplement to ARV Guidelines

  7. Partner’s Demonstration Project: Thika, Kenya Open-label PrEP for SDC study data used for preliminary costing exercise* HIVST sub-study: • Between quarterly clinic visits for PrEP prescriptions & HIV testing • HIVST training & distribution of kits for home use • Examining HIVST uptake, preferences etc. *Ngure, K et al. Uptake of HIV Self-testing among people receiving PrEP in Kenya R4P, 2014 [A-671-0020-00477]

  8. Estimating the annual cost of retesting Estimates based on 100 clients in 1st year of PrEPprogramme: • Commodities (rapid test kits, supplies), • Human resources: • 30 minutes counselling per facility test, • 30 minutes for initial HIVST training, • 10 minutes for subsequent HIVST • Support 24-hour telephone hotline • 98% enrollment into HIVST • Serial Algorithm: Determine & Unigold

  9. Option 1. Facility-based HIV testing Option 1: Standard facility-based testing algorithm using Determine, Unigold and ELISA test(no HIV self-testing). • In this model HIV negative users on PrEP re-test for HIV in a facilityevery 3 months.

  10. Option 2. Supervised HIVST in a facility Facility-based supervised HIV self-testing where users self-test in a private place within a facility every 3 months. • Less counselling, health worker simply provides support as needed. • Individuals with a reactive (positive) self-test result re-test as detailed in Option 1.

  11. Option 3: Unsupervised HIVST & facility-based HIV testing Alternating between quarterly (every 3 months) in-clinic facility-based testand at-home self-test. • Reactive (positive) self-tests re-test in a facility (see Option 1). • In one year: client visits facility every 6 months

  12. Annual Cost per Person as Cost of HIVST Kit Changes HIVST kits in Kenya cost ~10USD HIVST kits cost ~3USD in Malawi

  13. Annual HIV re-testing cost with PrEP implementation in Kenya per person $3 per HIVST Kit

  14. Sensitivity Analysis for Annual Re-Testing Cost per Person • Green = Least expensive of three options • Orange = Less expensive than facility-based testing • White= Facility-Based is least expensive

  15. Sensitivity Analysis for Annual Re-Testing Cost per Person • Green = Least expensive of three options • Orange = Less expensive than facility-based testing • White= Facility-Based is least expensive

  16. Key Findings • Re-testing with HIVST could be less costly than current facility-based re-testing • Annual re-testing with HIVST costs less than facility-based re-testing when: • HIVST kit is ≤5USD (supervised HIVST) • HIVST kit is ≤3USD (unsupervised HIVST) • Other re-testing scenarios using HIVST may also lead to cost-savings

  17. Key Findings • HIVST kits are expensive, but health worker time is more expensive. • Decreasing the amount of health worker time & cost of test kits can significantly reduce costs per person • Sensitivity analysis shows many scenarios where HIVST (supervised & unsupervised) can be less expensive

  18. Limitations • Preliminary costing exercise • Only factored in re-testing cost, not additional services • Did not factor in opportunity cost, public health benefit, other potential risks & benefits of re-testing with HIVST • Other scenarios of HIVST are possible • Only examined 1st year of re-testing costs • Questions remain about who and how many will be eligible for re-testing using HIVST • Who is most likely to benefit and how will providers identify who is eligible?

  19. Conclusion & Next Steps • Introducing supervised or unsupervised HIVST could: • Reduce number of facility visits • More private, convenient way to re-test • Reduce re-testing costs • HIVST kit cost ≤3USD to significantly reduce re-testing costs. • Research is needed to explore the cost-effectiveness of introducing HIVST within PrEPprogrammes • Analyses factoring opportunity costs, public health impact, and other potential risks and benefits.

  20. Acknowledgements Kathryn Curran, Kenneth Ngure, Rachel Baggaley, Jared Baeten, Nelly Mugo, Renee Heffron, Kevin O’Reilly, and Florence Koechlin

  21. Standard WHO Serial Algorithm Low prevalence ( < 5%) High prevalence ( < 5%)

  22. Option 1: Facility-based re-testing Facility HTC every 3 months Determine Positive Unigold Positive Elisa Negative Negative Negative Positive National Testing Algorithm Continue PrEP Diagnosis, stop PrEP

  23. Option 2: Facility-basedSupervised HIVST HIVST Training Facility-based HIVST re-testing every 3 months Negative Positive Continue PrEP Serial Algorithm: Determine & Unigold (see option 1)

  24. Option 3: Facility-based Unsupervised HIVST HIVST Training Facility HTC re-testing every 3 months Home HIVST re-testing every 3 months Negative Positive Positive Negative Diagnosis, stop PrEP Continue PrEPHIVST retest 3 months Continue PrEPfacility HTC retest 3 months Facility HTC: Serial Algorithm: Determine & Unigold (option 1)

More Related